Live Breaking News & Updates on துறை ஆஃப் செல்லுலார்|Page 4

Stay updated with breaking news from துறை ஆஃப் செல்லுலார். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma


Science for just $15 USD.
Short circuiting solid tumors
Two major hurdles in chimeric antigen receptor (CAR) T cell therapy for solid tumors are ensuring specificity to tumor cells without affecting healthy cells and avoiding tumor escape due to antigen loss. To address these challenges, Hyrenius-Wittsten
et al. and Choe
et al. developed synthetic notch (synNotch)–CAR T cells targeting solid tumor antigens and used them to treat mouse models of mesothelioma, ovarian cancer, and glioblastoma. In both studies, the authors demonstrated that synNotch-CAR T cells were better at controlling tumors than traditional CAR T cells and did not result in toxicity or damage to healthy tissue. These results suggest that synNotch-CAR T cells may be an effective treatment strategy for solid tumors. ....

United States , San Francisco , University Of California , Department Of Cellular , Cell Design Institute , Design Institute , Molecular Pharmacology , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா , துறை ஆஃப் செல்லுலார் , வடிவமைப்பு நிறுவனம் , மூலக்கூறு மருந்தியல் ,

Huntington's Disease: Neural traffic could help understand the disease


 E-Mail
IMAGE: In Huntington s Disease, axonal transport is defective and this leads to neuronal degeneration. In this work, we found that the protein mutated in Huntington s Disease, called huntingtin (HTT), needs to.
view more 
Credit: by University of Trento
Huntington s disease is a genetic neurodegenerative disorder caused by mutations in the protein huntingtin and characterized by involuntary dance-like movements, severe behavioural changes and cognitive impairment. That neuronal traffic is impaired in this disease has been very well known for several years. But that this deranged trafficking could be ameliorated by increasing huntingtin methylation was not yet known. The findings emerged from an international research work coordinated by the University of Trento and published in ....

United States , Alice Migazzi , Chiara Scaramuzzino , Maria Pennuto , Manuela Basso , Department Of Cellular , University Of Trento , Veneto Institute Of Molecular Medicine , University Of Trento Laboratory Transcriptional Neurobiology , Maria Pennuto University Of Padova , University Of Padova , Veneto Institute , Molecular Medicine , Integrative Biology , Transcriptional Neurobiology , Grenoble Institut Des , Fondazione Caritro , ஒன்றுபட்டது மாநிலங்களில் , துறை ஆஃப் செல்லுலார் , பல்கலைக்கழகம் ஆஃப் ட்ரெண்டோ , வெஂடோ நிறுவனம் ஆஃப் மூலக்கூறு மருந்து , பல்கலைக்கழகம் ஆஃப் ப்யாடோவ , வெஂடோ நிறுவனம் , மூலக்கூறு மருந்து , ஒருங்கிணைந்த உயிரியல் ,

Innovative cancer treatment effective in combating fungal infection in vitro and in mice


Innovative cancer treatment effective in combating fungal infection in vitro and in mice
An innovative cell-based treatment for cancer has been found promising for the control of infections caused by fungi. A study published in the journal
Cytotherapy reports that the use of CAR (chimeric antigen receptor) T-cells programmed to recognize
Cryptococcus spp. fungi was effective in combating infection in vitro and in mice.
C. gattii and
C. neoformans are present in soil with dead organic matter and places contaminated by the droppings of pigeons and other birds. They cause systemic mycoses in the human organism. They can infect the lungs and central nervous system, causing meningitis or meningoencephalitis. The symptoms vary according to the site of the infection, which can be fatal. Transmission occurs by inhalation of the fungi. ....

United States , Bioagents Biocel , Paulo Ribeir , Emily Henderson , Department Of Cellular , Preto Medical School , Dissemination Center , Us Centers For Disease , Drug Administration , Md Anderson Cancer Center , Disease Control , Thiago Aparecido , Molecular Biology , Pathogenic Bioagents , Brazilian Researcher , Young Investigator , Cancer Center , Cell Based Therapy , Cancer Treatment , Cell Wall , Central Nervous System , Chimeric Antigen Receptor , Cryptococcal Meningitis , Immune Response , In Vitro , Nervous System ,

Innovative cancer treatment found to be promising for the control of fungal infections


 E-Mail
An innovative cell-based treatment for cancer has been found promising for the control of infections caused by fungi. A study
published in the journal
Cryptococcus spp. fungi was effective in combating infection in vitro and in mice.
C. gattii and
C. neoformans are present in soil with dead organic matter and places contaminated by the droppings of pigeons and other birds. They cause systemic mycoses in the human organism. They can infect the lungs and central nervous system, causing meningitis or meningoencephalitis. The symptoms vary according to the site of the infection, which can be fatal. Transmission occurs by inhalation of the fungi. ....

United States , Bioagents Biocel , Paulo Ribeir , Department Of Cellular , Preto Medical School , Paulo Research Foundation , Dissemination Center , Us Centers For Disease , Drug Administration , Md Anderson Cancer Center , Disease Control , Thiago Aparecido , Molecular Biology , Pathogenic Bioagents , Young Investigator , Cancer Center , Cell Based Therapy , Cell Biology , Pharmaceutical Science , Pharmaceutical Chemistry , ஒன்றுபட்டது மாநிலங்களில் , துறை ஆஃப் செல்லுலார் , பிரெதோ மருத்துவ பள்ளி , பாலொ ஆராய்ச்சி அடித்தளம் , பரப்புதல் மையம் , எங்களுக்கு மையங்கள் க்கு நோய் ,